Acute lymphoblastic leukaemia (ALL) is a rare disease in the elderly. 急性淋巴细胞性白血病(ALL)在老年人中是一种罕见疾病。
Childhood acute lymphoblastic leukemia with myeloid antigen expression and its prognosis. 髓系抗原阳性儿童急性淋巴细胞白血病临床特点及预后。
Lymphoblastic lymphoma (LBL) represents approximately 30% of childhood and 3% of adult non-Hodgkin's lymphoma (NHL). 另外,LBL的发生率儿童约佔30%25,而3%25为成人非何杰金氏细胞瘤(NHL)。
Other names for ALL are acute lymphoblastic leukemia and acute lymphoid leukemia. 别名有,急性淋巴母细胞性白血病和急性淋巴性白血病。
L-ASP is used in the therapy of childhood acute lymphoblastic leukemia because of its antitumor activity. 综述近年来有关大肠杆菌来源的L-天冬酰胺酶的结构与功能、纯化工艺以及酶的修饰的研究进展。
Contemporary risk-directed therapy has advanced the cure rate for childhood acute lymphoblastic leukemia to near 80%. 目前危险指向性治疗使儿童急性淋巴细胞白血病的治愈率接近80%25。